Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1978 • 1,954 citations

A Class I Antigen, HLA-G, Expressed in Human Trophoblasts

1990 • 1,417 citations

Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance

1999 • 1,168 citations

Monoclonal Antibodies for Analysis of the HLA System

1979 • 745 citations

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

1986 • 547 citations

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

1996 • 515 citations

Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

2002 • 400 citations

An Evidence-based Staging System for Cutaneous Melanoma

2004 • 400 citations

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1999 • 366 citations

Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice

1974 • 328 citations

Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28

1981 • 327 citations

Characterization of a monoclonal anti‐β₂‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens

1979 • 308 citations

Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

1983 • 257 citations

A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17

1980 • 243 citations

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1995 • 225 citations

Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies

1983 • 190 citations

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1998 • 166 citations

Antigenicity and immunogenicity of Melan‐A/MART‐1 derived peptides as targets for tumor reactive CTL in human melanoma

2002 • 158 citations

β2-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide

2003 • 153 citations

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

1989 • 150 citations

Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.

1999 • 146 citations

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1998 • 143 citations

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

1989 • 127 citations

Why certain antibodies cross-react with HLA- A and HLA-G: Epitope mapping of two common MHC class I reagentsfn2fn2This work was supported by a grant from the National Institutes of Health (R01AI38577-01) and by a Reproductive Scientist Development Award, the Society for Gynecologic Investigation, and National Institutes of Health Grant K12HD00849 (to D.J.S.)

1998 • 126 citations

Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.

1983 • 125 citations

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1996 • 120 citations

The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells

1983 • 120 citations

HETEROGENEOUS DISTRIBUTION OF THE DETERMINANTS DEFINED BY MONOCLONAL ANTIBODIES ON HLA-A AND B ANTIGENS BEARING MOLECULES

1982 • 111 citations

Endoplasmic reticulum chaperone‐specific monoclonal antibodies for flow cytometry and immunohistochemical staining

2003 • 92 citations

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype

2003 • 92 citations

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

2000 • 84 citations

Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

1993 • 61 citations

Cutaneous Oncology: Pathophysiology, Diagnosis, and Management

1998 • 61 citations

Stimulation of HLA-A,B,C by IFN-alpha. The derivation of Molt 4 variants and the differential expression of HLA-A,B,C subsets.

1985 • 56 citations

FINE SPECIFICITY AND IDIOTYPE DIVERSITY OF THE MURINE ANTI-HLA-A2, A28 MONOCLONAL ANTIBODIES CR11–351 AND KS1

1988 • 49 citations

Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma.

1996 • 45 citations

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

1985 • 40 citations

The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region

1981 • 40 citations

Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: Specificity, idiotypes, and application for a double determinant immunoassay

1988 • 31 citations

Identification of the amino acid residues defining an intralocus determinant in the α1 domain of HLA-A molecules

1989 • 30 citations

High Frequency of Melanoma-Associated Antigen or HLA Class I Loss Does Not Correlate with Survival in Primary Melanoma

2003 • 23 citations

Specificity and functional characteristics of anti‐HLA‐A mAbs LGIII‐147.4.1 and LGIII‐220.6.2

2003 • 22 citations

Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients

2001 • 12 citations